Please use this identifier to cite or link to this item:
Title: BMI and adipocytokine changes in COPD exacerbation and stable COPD
Authors: Cambay, Zafer
Ilhan, Nevin
Susam, Solmaz
Muz, Mehmet Hamdi
Keywords: Adiponectin;Chronic obstructive pulmonary disease (COPD);Interleukin-6;Malondialdehyde (MDA);Visfatin
Issue Date: Oct-2021
Publisher: NIScPR-CSIR, India
Abstract: COPD is described by progressive airflow restriction and recurrent acute exacerbations, which is caused by inflammatory response occurring in lungs as a result of chronic inhalation of harmful particles and gases. The study was designed to determine the link of interleukin-6 (IL-6), adiponectin and visfatin with BMI and oxidant/antioxidant balance in Chronic Obstructive Pulmonary Disease (COPD), a systemic disease. The study comprised control (n=20), patients with COPD (n=37) from the Chest Diseases Clinic of Firat University Hospital. The serum MDA, IL-6, Visfatin and Adiponectin levels were evaluated by ELISA. Also, Pulmonary Function Tests were done. There was no significant difference between control and patients with COPD in terms of sex and age averages. On the contrary, BMI levels were statistically significantly lower in COPD group compared to the controls. MDA and adiponectin levels were higher, IL-6 and visfatin levels were lower in COPD groups contrary to controls. It was thought that the level changes of these parameters (MDA, IL-6, visfatin and adiponectin) may be an important factor in the development of COPD and in monitoring the treatment of COPD-related diseases.
Page(s): 472-477
ISSN: 0975-0959 (Online); 0301-1208 (Print)
Appears in Collections:IJBB Vol.58(5) [October 2021]

Files in This Item:
File Description SizeFormat 
IJBB 58 (5) 472-477 Oct 2021.pdf287.23 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.